#ACTRIMS2020 – IL-13 May Be ‘Attractive’ Target for Easing Inflammation in MS
A signaling molecule of the immune system called interleukin 13 (IL-13) may modulate the function of key immune cells involved in multiple sclerosis (MS), and their migration through the barrier that protects the brain and spinal cord. IL-13 is an “attractive molecule” and a potential avenue for treating MS,…